<DOC>
	<DOCNO>NCT00344903</DOCNO>
	<brief_summary>The Dallas Heart Study ( DHS-1 ) large , multi-ethnic , population-based epidemiological study design identify determinant atherosclerotic heart disease ( ASHD ) representative United States ( US ) urban environment . This study complete enrollment 2003 . Our objective pinpoint factor contribute progression : 1. health ASHD risk ; 2. ASHD risk subclinical ASHD ; 3. subclinical clinical ASHD . Identification critical factor transition enable target implementation appropriate therapy interdict clinical ASHD develops .</brief_summary>
	<brief_title>Dallas Heart Study 2 : Return Clinic Visit Dallas Heart Study Cohort</brief_title>
	<detailed_description>Early medical intervention asymptomatic individual risk effective strategy combat atherosclerotic heart disease ( ASHD ) . The major roadblock effective ASHD prevention conventional tool assess ASHD risk inadequate new method need identify susceptible individual disease process establish . Other successful public-health screening program incorporate direct imaging procedure ( e.g . mammography , colonoscopy ) ; yet ASHD , direct imaging vasculature incorporate risk stratification algorithm . The Dallas Heart Study ( DHS-1 ) large , multi-ethnic , population-based epidemiological study design identify determinant ASHD representative US urban environment . This study complete enrollment 2003 . In DHS-2 transform Dallas Heart Study cross-sectional health survey ( DHS-1 ) longitudinal cohort study ( DHS-2 ) . We perform state-of-the-art cardiovascular ( CV ) image couple biomarkers , genetic marker classical ASHD risk factor . We repeat detailed clinical phenotyping perform 2000-2003 capture interval change ASHD risk disease burden . Our objective pinpoint factor contribute progression : 1. health ASHD risk ; 2. ASHD risk subclinical ASHD ; 3. subclinical clinical ASHD . Identification critical factor transition enable target implementation appropriate therapy interdict clinical ASHD develops .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<criteria>Age 3570 Participant DHS1 study complete visit 2 ( blood sample ) visit 3 ( clinic visit ) Provision inform consent Nonepopulation study</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Ventricular Hypertrophy</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Screening</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Obesity</keyword>
	<keyword>Metabolic Syndrome</keyword>
</DOC>